PMCB logo

PharmaCyte Biotech (PMCB) Total Liabilities

Annual Total Liabilities

$20.39 M
+$19.80 M+3375.84%

April 30, 2024

Summary

Performance

1-Year Change

+3375.84%

3-Year Change

+2713.09%

5-Year Change

+2644.56%

15-Year Change

+3414.18%

PMCB Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.96%
PMCB annual total liabilities is higher than 32.96% of companies in Healthcare sector

High & Low

All-time High

$20.39 M
PMCB annual total liabilities is currently at an all-time high

3-Year Low

$586.60 K
PMCB annual total liabilities is currently +3375.84% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Apr 30, 2024
PMCB previous annual earnings announcement was published on Apr 30, 2024

Next Annual Earnings Report Date

N/A
PMCB next annual earnings announcement has not yet been scheduled

OtherPMCBbalance sheetmetrics:

Quarterly Current Liabilities

$4.78 M
PMCB quarterly total current liabilities is $4.78 million

Quarterly Long Term Liabilities

$6.87 M
PMCB quarterly total long term liabilities is $6.87 million

Quarterly Total Assets

$55.10 M
PMCB quarterly total assets is $55.10 million

Quarterly Current Assets

$21.33 M
PMCB quarterly total current assets is $21.33 million

Quarterly Total Liabilities

$11.65 M
-$5.51 M-32.10%

October 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+1307.01%

5-Year Change

+1307.01%

PMCB Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.77%
PMCB quarterly total liabilities is higher than 26.77% of companies in Healthcare sector

High & Low

All-time High

$22.47 M
PMCB quarterly total liabilities is currently -48.16% below its historical high of $22.47 million

3-Year Low

$586.60 K
PMCB quarterly total liabilities is currently +1885.54% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
PMCB previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
PMCB next earnings announcement is scheduled for Mar 18, 2025

OtherPMCBbalance sheetmetrics:

Quarterly Current Liabilities

$4.78 M
PMCB quarterly total current liabilities is $4.78 million

Quarterly Long Term Liabilities

$6.87 M
PMCB quarterly total long term liabilities is $6.87 million

Quarterly Total Assets

$55.10 M
PMCB quarterly total assets is $55.10 million

Quarterly Current Assets

$21.33 M
PMCB quarterly total current assets is $21.33 million

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

Annual Total Liabilities

$20.39 M
PMCB annual total liabilities is $20.39 million

Annual Current Liabilities

$7.42 M
PMCB annual total current liabilities is $7.42 million

Annual Total Long Term Liabilities

$12.97 M
PMCB annual total long term liabilities is $12.97 million

PMCB Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3375.8%0.0%
3 y3 years+2713.1%+1307.0%
5 y5 years+2644.6%+1307.0%

PMCB Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+3375.8%-48.2%+1885.5%
5 y5-yearat high+3375.8%-48.2%+6158.6%
alltimeall timeat high>+9999.0%-48.2%>+9999.0%

PharmaCyte Biotech Total Liabilities History

DateAnnualQuarterly
Oct 2024
-
$11.65 M(-32.1%)
Jul 2024
-
$17.15 M(-15.9%)
Apr 2024
$20.39 M(+3375.8%)
$20.39 M(-9.2%)
Jan 2024
-
$22.47 M(+7.9%)
Oct 2023
-
$20.81 M(+2.0%)
Jul 2023
-
$20.40 M(+3377.2%)
Apr 2023
$586.60 K(-16.7%)
$586.60 K(-29.1%)
Jan 2023
-
$827.80 K(-36.9%)
Oct 2022
-
$1.31 M(+20.4%)
Jul 2022
-
$1.09 M(+54.7%)
Apr 2022
$704.40 K(-2.8%)
$704.40 K(+14.9%)
Jan 2022
-
$613.00 K(+229.4%)
Oct 2021
-
$186.10 K(-79.9%)
Jul 2021
-
$925.00 K(+27.6%)
Apr 2021
$724.80 K(-32.7%)
$724.80 K(+11.7%)
Jan 2021
-
$648.70 K(-2.4%)
Oct 2020
-
$664.70 K(-44.0%)
Jul 2020
-
$1.19 M(+10.1%)
Apr 2020
$1.08 M(+45.1%)
$1.08 M(+5.8%)
Jan 2020
-
$1.02 M(+26.7%)
Oct 2019
-
$803.90 K(+32.5%)
Jul 2019
-
$606.60 K(-18.3%)
Apr 2019
$742.90 K(+15.3%)
$742.90 K(+57.7%)
Jan 2019
-
$471.20 K(-28.9%)
Oct 2018
-
$662.40 K(-25.0%)
Jul 2018
-
$882.90 K(+37.1%)
Apr 2018
$644.20 K(+11.0%)
$644.20 K(-27.4%)
Jan 2018
-
$887.20 K(+56.5%)
Oct 2017
-
$567.00 K(-34.5%)
Jul 2017
-
$865.70 K(+49.2%)
Apr 2017
$580.20 K(-9.0%)
$580.20 K(+0.3%)
Jan 2017
-
$578.30 K(+28.8%)
Oct 2016
-
$449.00 K(-1.6%)
Jul 2016
-
$456.50 K(-28.4%)
Apr 2016
$637.60 K(-58.1%)
$637.60 K(-40.2%)
Jan 2016
-
$1.07 M(-1.4%)
Oct 2015
-
$1.08 M(-9.0%)
Jul 2015
-
$1.19 M(-22.0%)
Apr 2015
$1.52 M(+306.9%)
$1.52 M(+301.7%)
Jan 2015
-
$378.50 K(+36.7%)
Oct 2014
-
$276.90 K(-25.4%)
Jul 2014
-
$371.40 K(-0.6%)
Apr 2014
$373.70 K
$373.70 K(-22.0%)
Jan 2014
-
$479.30 K(-51.6%)
DateAnnualQuarterly
Oct 2013
-
$991.00 K(-0.3%)
Jul 2013
-
$994.20 K(-73.8%)
Apr 2013
$3.80 M(+0.3%)
$3.80 M(-2.6%)
Jan 2013
-
$3.90 M(-10.8%)
Oct 2012
-
$4.37 M(-5.1%)
Jul 2012
-
$4.61 M(+21.6%)
Apr 2012
$3.79 M(-4.6%)
$3.79 M(-7.9%)
Jan 2012
-
$4.11 M(+0.3%)
Oct 2011
-
$4.10 M(+3.0%)
Jul 2011
-
$3.98 M(+0.3%)
Apr 2011
$3.97 M(+8.7%)
$3.97 M(+16.4%)
Jan 2011
-
$3.41 M(+3.0%)
Oct 2010
-
$3.31 M(+1.3%)
Jul 2010
-
$3.27 M(-10.5%)
Apr 2010
$3.65 M(+25.3%)
$3.65 M(+17.9%)
Jan 2010
-
$3.10 M(+4.8%)
Oct 2009
-
$2.96 M(+3.5%)
Jul 2009
-
$2.86 M(-2.1%)
Apr 2009
$2.92 M(+1514.6%)
$2.92 M(+2753.2%)
Jan 2009
-
$102.20 K(+26.8%)
Oct 2008
-
$80.60 K(+61.8%)
Jul 2008
-
$49.80 K(-72.4%)
Apr 2008
$180.60 K(+52.0%)
$180.60 K(+75.0%)
Jan 2008
-
$103.20 K(-2.8%)
Oct 2007
-
$106.20 K(+55.0%)
Jul 2007
-
$68.50 K(-42.3%)
Apr 2007
$118.80 K(-83.6%)
$118.80 K(-92.5%)
Jan 2007
-
$1.58 M(+106.4%)
Oct 2006
-
$767.00 K(+5.4%)
Jul 2006
-
$728.00 K(+0.6%)
Apr 2006
$723.90 K(-55.6%)
$723.90 K(-53.5%)
Jan 2006
-
$1.56 M(-11.7%)
Oct 2005
-
$1.76 M(+0.1%)
Jul 2005
-
$1.76 M(+7.9%)
Apr 2005
$1.63 M(+395.7%)
$1.63 M(-46.9%)
Jan 2005
-
$3.07 M(+1.1%)
Oct 2004
-
$3.04 M(+1.6%)
Jul 2004
-
$2.99 M(+809.4%)
Apr 2004
$329.10 K(>+9900.0%)
$329.10 K(+245.7%)
Jan 2004
-
$95.20 K(+1600.0%)
Oct 2003
-
$5600.00(+30.2%)
Jul 2003
-
$4300.00(+72.0%)
Apr 2003
$2500.00(-68.4%)
$2500.00(-71.9%)
Jan 2003
-
$8900.00
Apr 2002
$7900.00
-

FAQ

  • What is PharmaCyte Biotech annual total liabilities?
  • What is the all time high annual total liabilities for PharmaCyte Biotech?
  • What is PharmaCyte Biotech annual total liabilities year-on-year change?
  • What is PharmaCyte Biotech quarterly total liabilities?
  • What is the all time high quarterly total liabilities for PharmaCyte Biotech?
  • What is PharmaCyte Biotech quarterly total liabilities year-on-year change?

What is PharmaCyte Biotech annual total liabilities?

The current annual total liabilities of PMCB is $20.39 M

What is the all time high annual total liabilities for PharmaCyte Biotech?

PharmaCyte Biotech all-time high annual total liabilities is $20.39 M

What is PharmaCyte Biotech annual total liabilities year-on-year change?

Over the past year, PMCB annual total liabilities has changed by +$19.80 M (+3375.84%)

What is PharmaCyte Biotech quarterly total liabilities?

The current quarterly total liabilities of PMCB is $11.65 M

What is the all time high quarterly total liabilities for PharmaCyte Biotech?

PharmaCyte Biotech all-time high quarterly total liabilities is $22.47 M

What is PharmaCyte Biotech quarterly total liabilities year-on-year change?

Over the past year, PMCB quarterly total liabilities has changed by $0.00 (0.00%)